« Previous
Next »
Archives of Medical Research
Volume 41, Issue 2
, Pages 125-133
, February 2010
Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer: A Meta-analysis
References
- . Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–362
- Trends in Helicobacter pylori infection and gastric cancer in Mexico. Cancer Epidemiol Biomarkers Prev. 2005;14:1874–1877
- . Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002;100:249–260
- Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:115–121
- Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000;9:849–853
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
- A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169–172
- . Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost. 1997;78:523–526
- The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab. 2006;88:290–294
- A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr. 1999;129:1656–1661
- MTHFR 677C/T polymorphism and risk of coronary heart disease: a metaanalysis. JAMA. 2002;288:2023–2031
- A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med. 2001;79:522–528
- The effect of 677C/T and 1298A/C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr. 2000;83:593–596
- . Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–137
- . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
- . Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826
- . A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med. 2006;25:3443–3457
- Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:1054–1058
- Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev. 2004;5:133–138
- Interactions between lifestyle, methylanetetrahydrofolate reductase gene and polymorphisms in thymidylate synthase gene with risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24:599–603
- A case-control study on the relationship between methyl-tetra-hydrofolic acid reductase 677 gene polymorphism and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:495–498
- Single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and susceptibility to cancer of the gastric cardia in Chinese population. Zhonghua Yi Xue Za Zhi. 2002;82:669–672
- Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001;95:332–336
- Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:289–292
- Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers. 2007;12:61–75
- Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev. 2002;11:1454–1458
- Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol Rep. 2005;13:355–360
- . Study on C667T gene polymorphism and susceptibility to gastric cancer. Chin J Public Health. 2005;21:661–663
- Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis. Eur J Cancer Prev. 2008;17:446–452
- Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers. 2007;12:635–644
- Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett. 2007;251:228–236
- Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer. 2006;118:628–632
- Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol. 2005;40:109–111
- Application of microarray-based method for methylenetetrahydrofolate reductase (MTHFR) polymorphisms in the risk of gastric carcinoma in east China population. J Nanosci Nanotechnol. 2007;7:3245–3249
- Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control. 2007;18:143–152
- Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J Gastroenterol. 2006;12:7591–7597
- The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:794–799
- Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res. 2005;25:2249–2252
- Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus. 2005;18:177–184
- Esophageal and gastric cardia cancer risk and folate- and vitamin B12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev. 2003;12:1222–1226
- Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr. 2009;48:269–276
- C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex. 2007;72:355–358
- Methylenetetrahydrofolate reductase 677C >T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer. 2006;42:528–533
- The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007;16:2416–2424
- Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct. 2007;25:419–422
- Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol. 2008;167:505–516
- . Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet. 2006;51:618–624
- . Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology. 2006;131:1271–1283
- . Folate and antifolate pharmacology. Semin Oncol. 1997;24:S18–30–S18–39
- . Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet. 2006;69:327–3361
- Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 2001;61:3272–3275
- . Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol. 2000;13:20–33
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–113
- . Folate status assessment. J Nutr. 1990;120(Suppl):1508–1511
PII: S0188-4409(10)00002-0
doi: 10.1016/j.arcmed.2010.01.001
© 2010 IMSS. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Archives of Medical Research
Volume 41, Issue 2
, Pages 125-133
, February 2010
